Rights and permissions
About this article
Cite this article
Oprelvekin “not worth the cost” for thrombocytopenia prophylaxis. Pharmacoecon. Outcomes News 422, 7 (2003). https://doi.org/10.1007/BF03276550
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276550